Assessment of the in vitro γH2AX assay by High Content Screening as a novel genotoxicity test

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 757, Issue 2, 2013, Pages 158-166

  Garcia Canton, Carolina ^a,b   Anadon, Arturo ^b   Meredith, Clive ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

H2AX; DNA damage; Double strand breaks; Genotoxicity; In vitro

Indexed keywords

HISTONE H2AX; HISTONE H2AX GAMMA; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; AUTOMATION; CELL VIABILITY; COMPUTER PROGRAM; DNA DAMAGE; DNA SYNTHESIS; GENOTOXICITY; HIGH CONTENT SCREENING; HIGH THROUGHPUT SCREENING; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ΓH2AX; DNA DAMAGE; DOUBLE STRAND BREAKS; GENOTOXICITY; IN VITRO;

BIOLOGICAL MARKERS; BRONCHI; CELL LINE; DNA DAMAGE; EPITHELIAL CELLS; HISTONES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MUTAGENICITY TESTS; RESPIRATORY MUCOSA; SENSITIVITY AND SPECIFICITY;

EID: 84885869334     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.08.002     Document Type: Article

References (54)

1. Mahadevan B., Snyder R.D., Waters M.D., Benz R.D., Kemper R.A., Tice R.R., Richard A.M. Genetic toxicology in the 21st century: reflections and future directions. Environ. Mol. Mutagen. 2011, 52:339-354.
2. COM A Strategy for Testing of Chemicals for Genotoxicity 2011, http://www.iacom.org.uk/guidstate/documents/COMGuidanceFINAL2.pdf.
3. ICH, Topic S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use 2011, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Saf ety/S2_R1/Step4/S2R1_Step4.pdf.
4. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H., Hastwell P., Hayashi M., Kasper P., Kirchner S., Lynch A., Marzin D., Maurici D., Meunier J.R., Muller L., Nohynek G., Parry J., Parry E., Thybaud V., Tice R., van Benthem J., Vanparys P., White P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res. 2007, 628:31-55.
5. European Commission Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off. J. Eur. Union 2003, L66:26-35.
6. Kirkland D., Aardema M., Banduhn N., Carmichael P., Fautz R., Meunier J.R., Pfuhler S. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis 2007, 22:161-175.
7. Lynch A.M., Sasaki J.C., Elespuru R., Jacobson-Kram D., Thybaud V., De Boeck M., Aardema M.J., Aubrecht J., Benz R., Dertinger S.D., Douglas G.R., White P.A., Escobar P.A., Fornace A., Honma M., Naven R.T., Rusling J.F., Schiestl R.H., Walmsley R.M., Yamamura E., van Benthem J., Kim J.H. New and emerging technologies for genetic toxicity testing. Environ. Mol. Mutagen. 2011, 52:205-223.
8. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
9. Dickey J.S., Redon C.E., Nakamura A.J., Baird B.J., Sedelnikova O.A., Bonner W.M. H2AX: functional roles and potential applications. Chromosoma 2009, 118:683-692.
10. Redon C.E., Nakamura A.J., Martin O.A., Parekh P.R., Weyemi U.S., Bonner W.M. Recent developments in the use of gamma-H2AX as a quantitative DNA double-strand break biomarker. Aging 2011, 3:168-174.
11. Bickle M. The beautiful cell: high-content screening in drug discovery. Anal. Bioanal. Chem. 2010, 398:219-226.
12. Smart D.J., Ahmedi K.P., Harvey J.S., Lynch A.M. Genotoxicity screening via the gammaH2AX by flow assay. Mutat. Res. 2011, 715:25-31.
13. Tsamou M., Jennen D.G., Claessen S.M., Magkoufopoulou C., Kleinjans J.C. J. H. van Delft. Performance of in vitro gammaH2AX assay in HepG2 cells to predict in vivo genotoxicity. Mutagenesis 2012, 27:645-652.
14. Banath J.P., Olive P.L. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res. 2003, 63:4347-4350.
15. Sedelnikova O.A., Rogakou E.P., Panyutin I.G., Bonner W.M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat. Res. 2002, 158:486-492.
16. Taylor D.L. A personal perspective on high-content screening (HCS): from the beginning. J. Biomol. Screen. 2010, 15:720-725.
17. Kirkland D., Kasper P., Muller L., Corvi R., Speit G. Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat. Res. 2008, 653:99-108.
18. Hastwell P.W., Chai L.L., Roberts K.J., Webster T.W., Harvey J.S., Rees R.W., Walmsley R.M. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat. Res. 2006, 607:160-175.
19. Bonner W.M., Redon C.E., Dickey J.S., Nakamura A.J., Sedelnikova O.A., Solier S., Pommier Y. GammaH2AX and cancer. Nat. Rev. Cancer 2008, 8:957-967.
20. Fowler P., Smith K., Young J., Jeffrey L., Kirkland D., Pfuhler S., Carmichael P. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutat. Res. 2012, 742:11-25.
21. Reddel R.R., Ke Y., Gerwin B.I., McMenamin M.G., Lechner J.F., Su R.T., Brash D.E., Park J.B., Rhim J.S., Harris C.C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 1988, 48:1904-1909.
22. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
23. Fernandez-Capetillo O., Lee A., Nussenzweig M., Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 2004, 3:959-967.
24. Downey M., Durocher D. gamma H2AX as a checkpoint maintenance signal. Cell Cycle 2006, 5:1376-1381.
25. Svetlova M.P., Solovjeva L.V., Tomilin N.V. Mechanism of elimination of phosphorylated histone H2AX from chromatin after repair of DNA double-strand breaks. Mutat. Res. 2010, 685:54-60.
26. Garcia-Canton C., Minet E., Anadon A., Meredith C. Metabolic characterization of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B as a working example. Toxicol. In Vitro 2013, 27:1719-1727.
27. Nims R.W., Sykes G., Cottrill K., Ikonomi P., Elmore E. Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification. In Vitro Cell. Dev. Biol. Anim. 2010, 46:811-819.
28. Kirkland D., Aardema M., Henderson L., Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res. 2005, 584:1-256.
29. TOXNET Toxicology Data Network, (accessed February 2013). http://toxnet.nlm.nih.gov/.
30. NTP National Toxicology Program, (accessed February 2013). http://ntp-server.niehs.nih.gov/.
31. IARC IARC monographs on the evaluation of carcinogenic risk to humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents 2000, International Agency for Research on Cancer, 76.
32. IARC IARC monographs on the evaluation of carcinogenic risk to humans. Overall evaluation of carcinogenicity: an updating of IARC monographs 1987, vols. 1-42, suppl. 7. International Agency for Research on Cancer.
33. Staszewski O., Nikolova T., Kaina B. Kinetics of gamma-H2AX focus formation upon treatment of cells with UV light and alkylating agents. Environ. Mol. Mutagen. 2008, 49:734-740.
34. Gursoy-Yuzugullu O., Yuzugullu H., Yilmaz M., Ozturk M. Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation. Liver Int. 2011, 31:561-571.
35. Kim S., Jun D.H., Kim H.J., Jeong K.C., Lee C.H. Development of a high-content screening method for chemicals modulating DNA damage response. J. Biomol. Screen. 2011, 16:259-265.
36. Matsuzaki K., Harada A., Takeiri A., Tanaka K., Mishima M. Whole cell-ELISA to measure the gammaH2AX response of six aneugens and eight DNA-damaging chemicals. Mutat. Res. 2010, 700:71-79.
37. Tanaka T., Huang X., Halicka H.D., Zhao H., Traganos F., Albino A.P., Dai W., Darzynkiewicz Z. Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 2007, 71:648-661.
38. Dalton W.B., Yu B., Yang V.W. p53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene 2010, 29:1929-1940.
39. Munroe R., Schimenti J. Mutagenesis of mouse embryonic stem cells with ethylmethanesulfonate. Methods Mol. Biol. 2009, 530:131-138.
40. Garcia-Canton C., Anadon A., Meredith C. gammaH2AX as a novel endpoint to detect DNA damage: applications for the assessment of the in vitro genotoxicity of cigarette smoke. Toxicol. In Vitro 2012, 26:1075-1086.
41. Wischermann K., Boukamp P., Schmezer P. Improved alkaline comet assay protocol for adherent HaCaT keratinocytes to study UVA-induced DNA damage. Mutat. Res. 2007, 630:122-128.
42. Lyman S.K., Crawley S.C., Gong R., Adamkewicz J.I., McGrath G., Chew J.Y., Choi J., Holst C.R., Goon L.H., Detmer S.A., Vaclavikova J., Gerritsen M.E., Blake R.A. High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888. PLoS ONE 2011, 6:e17692.
43. Chan G.K., Kleinheinz T.L., Peterson D., Moffat J.G. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS ONE 2013, 8:e63583.
44. Ma Y., Han J., Guo Y., Lam P.K., Wu R.S., Giesy J.P., Zhang X., Zhou B. Disruption of endocrine function in in vitro H295R cell-based and in in vivo assay in zebrafish by 2,4-dichlorophenol. Aquat. Toxicol. 2012, 106-107:173-181.
45. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 2000, 27:75-93.
46. Amer S.M., Aly F.A. Genotoxic effect of 2,4-dichlorophenoxy acetic acid and its metabolite 2,4-dichlorophenol in mouse. Mutat. Res. 2001, 494:1-12.
47. IARC IARC Monographs on the evaluation of carcinogenic risks to humans. Some aromatic amines, organic dyes, and related exposures, 99 2010.
48. Zhou C., Li Z., Diao H., Yu Y., Zhu W., Dai Y., Chen F.F., Yang J. DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors. Mutat. Res. 2006, 604:8-18.
49. Aardema M.J., Albertini S., Arni P., Henderson L.M., Kirsch-Volders M., Mackay J.M., Sarrif A.M., Stringer D.A., Taalman R.D. Aneuploidy: a report of an ECETOC task force. Mutat. Res. 1998, 410:3-79.
50. Yamada H.Y., Gorbsky G.J. Spindle checkpoint function and cellular sensitivity to antimitotic drugs. Mol. Cancer Ther. 2006, 5:2963-2969.
51. Scott D., Galloway S.M., Marshall R.R., Ishidate M., Brusick D., Ashby J., Myhr B.C. International commission for protection against environmental mutagens and carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat. Res. 1991, 257:147-205.
52. Mukherjee B., Kessinger C., Kobayashi J., Chen B.P., Chen D.J., Chatterjee A., Burma S. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair (Amst.) 2006, 5:575-590.
53. Darzynkiewicz Z., Zhao H., Halicka H.D., Rybak P., Dobrucki J., Wlodkowic D. DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosis. Crit. Rev. Clin. Lab. Sci. 2012, 49:199-217.
54. Audebert M., Riu A., Jacques C., Hillenweck A., Jamin E.L., Zalko D., Cravedi J.P. Use of the gammaH2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. Toxicology Letters 2010, 199:182-192.